Results 191 to 200 of about 12,338 (219)

Bortezomib

Reactions Weekly, 2016
  +4 more sources

Bortezomib

Reactions Weekly, 2015
  +4 more sources

Bortezomib

Reactions Weekly, 2019
  +6 more sources

Once-per-week selinexor, bortezomib, and dexamethasone versus twice-per-week bortezomib and dexamethasone in patients with multiple myeloma (BOSTON): a randomised, open-label, phase 3 trial

Lancet, The, 2020
Sebastian Grosicki, Ivan Spicka, Maria Gavriatopoulou   +2 more
exaly  

Bortezomib

Reactions Weekly, 2014
openaire   +2 more sources

Bortezomib

Reactions Weekly, 2023
openaire   +1 more source

PANORAMA 2: panobinostat in combination with bortezomib and dexamethasone in patients with relapsed and bortezomib-refractory myeloma

Blood, 2013
Paul G Richardson, Robert L Schlossman, Steven E Coutré   +2 more
exaly  

Bortezomib, doxorubicin and dexamethasone in advanced multiple myeloma

Annals of Oncology, 2008
Tommaso Caravita, F Morabito, Benedetto Bruno   +2 more
exaly  

Bortezomib (VELCADE®) in metastatic breast cancer: pharmacodynamics, biological effects, and prediction of clinical benefits

Annals of Oncology, 2006
C H Yang, A M Gonzalez-Angulo, J M Reuben   +2 more
exaly  

Bortezomib inhibits tumor adaptation to hypoxia by stimulating the FIH-mediated repression of hypoxia-inducible factor-1

Blood, 2008
Dong Hoon Shin, Yang-Sook Chun, Dong Soon Lee   +2 more
exaly